Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Imaging Products Company (MIP) is a specialized provider of equipment, chemical precursors, and consumables for the radiopharmaceutical and molecular imaging industries. Based in Ann Arbor, Michigan, the company focuses on the development and distribution of automated synthesis modules and high-quality precursors used in Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) research. Acquired by Eckert & Ziegler in 2010, MIP now operates as a key component of their Radiopharma segment, supporting the global production of diagnostic and therapeutic isotopes. Their product portfolio includes the Modular-Lab synthesis system, sterile components, and specialized radiochemicals for clinical and preclinical imaging applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Imaging Products.